Dr. Jackson Wang, MD

Dr. Wang practices at Grass Valley Dialysis in Roseville, California.

Dr. Wang's NPI, 1003183617, was assigned on November 28, 2011. Dr. Wang graduated from St. George's University School of Medicine in 2008. Dr. Wang's California license number on file is A119259.

Dr. Wang's primary practice is Grass Valley Dialysis, at 151 N Sunrise Ave, Roseville, CA 95661 in Placer County. The practice phone is (530) 477-0734.

Dr. Wang's primary practice is Grass Valley Dialysis in Roseville, California. Dr. Wang is also affiliated with Sutter Roseville Medical Center. The medical group on file is Summit Nephrology. Dmand AI also links Dr. Wang to 4 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Wang is board certified in internal medicine by the American Board of Internal Medicine. Dr. Wang has a license on file in California.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and parathyroid gland disorder among the conditions Dr. Wang treats.

CMS data shows 1,526 Medicare services from Dr. Wang across 12 procedure codes in 2024, for 473 Medicare patients. Medicare paid $161,357 for them.

CMS counts 473 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 185 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 4.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 78, with 45% women.

In 2024, Dr. Wang wrote 2,107 Medicare Part D claims for 370 patients. 90% of them were for generic drugs. CMS names the drug for 1,793 of them, across 36 drugs with 11 or more claims each, at $240,835 in total drug cost. In 2023, CMS named 2,156 claims across 43 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 2 papers to Dr. Wang, published from 2016 to 2024. Dr. Wang's most frequent co-author is Andrew I-Wei Chin, MD.

Dmand AI links Dr. Wang to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 79 general payments to Dr. Wang from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Relypsa, Inc. paid the most, $854.

Dr. Wang graduated from St. George's University School of Medicine in 2008.

Dr. Wang is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.